Efficacy of favipiravir in COVID-19 treatment: a multi-center randomized study
Efficacy of favipiravir in COVID-19 treatment: a multi-center randomized study
About this item
Full title
Author / Creator
Publisher
Austria: Springer Vienna
Journal title
Language
English
Formats
Publication information
Publisher
Austria: Springer Vienna
Subjects
More information
Scope and Contents
Contents
No specific antiviral drugs have been approved for the treatment of COVID-19. This study aimed to evaluate the efficacy of favipiravir in treatment of COVID-19. This was a multicenter randomized controlled study including 96 patients with COVID- 19 who were randomly assigned into a chloroquine (CQ) group and a favipiravir group. None of the patient...
Alternative Titles
Full title
Efficacy of favipiravir in COVID-19 treatment: a multi-center randomized study
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7829645
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7829645
Other Identifiers
ISSN
0304-8608
E-ISSN
1432-8798
DOI
10.1007/s00705-021-04956-9
